Fanny Cavalié
Chief Operating Officer bij FOGHORN THERAPEUTICS INC.
Vermogen: 509 906 $ op 31-03-2024
Profiel
Fanny Cavalié is currently the Chief Strategy & Business Operations Officer at Foghorn Therapeutics, Inc. She previously worked at Biogen, Inc. as the Head-Multiple Sclerosis Portfolio Strategy from 2014 to 2018.
Prior to that, she was an Associate Partner at McKinsey & Co., Inc. (United Kingdom) from 2003 to 2014.
Ms. Cavalié holds an MBA from École des Hautes Études Commerciales de Paris, which she obtained in 2001.
Bekende belangen in openbare bedrijven
Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
---|---|---|---|---|
11-03-2024 | 75 992 ( 0.18% ) | 509 906 $ | 31-03-2024 |
Actieve functies van Fanny Cavalié
Bedrijven | Functie | Begin |
---|---|---|
FOGHORN THERAPEUTICS INC. | Chief Operating Officer | - |
Eerdere bekende functies van Fanny Cavalié
Bedrijven | Functie | Einde |
---|---|---|
BIOGEN INC. | Corporate Officer/Principal | 01-03-2018 |
McKinsey & Co., Inc. (United Kingdom)
McKinsey & Co., Inc. (United Kingdom) Investment ManagersFinance Part of McKinsey & Co., Inc., McKinsey & Co., Inc. (United Kingdom) is a consulting firm that helps UK manufacturers embrace new technologies for digital transformation and leadership. The private company is based in London, UK. Ruben Schaubroeck, McKinsey Digital's new lead for the UK, Belgium, and Netherlands offices, spoke with Thomas Farrar, a manager of communications in the firm's UK office, about the importance of speed and pace for CEOs in this new growth journey. The British company works with organizations that pursue sustainability, inclusion, and economic growth, all at the same time, to achieve strategic foresight and built-in agility in the face of the COVID-19 pandemic and the new trading relationship with the EU. | Corporate Officer/Principal | 01-05-2014 |
Opleiding van Fanny Cavalié
École des Hautes Études Commerciales de Paris | Masters Business Admin |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 2 |
---|---|
BIOGEN INC. | Health Technology |
FOGHORN THERAPEUTICS INC. | Health Technology |
Bedrijven in privébezit | 1 |
---|---|
McKinsey & Co., Inc. (United Kingdom)
McKinsey & Co., Inc. (United Kingdom) Investment ManagersFinance Part of McKinsey & Co., Inc., McKinsey & Co., Inc. (United Kingdom) is a consulting firm that helps UK manufacturers embrace new technologies for digital transformation and leadership. The private company is based in London, UK. Ruben Schaubroeck, McKinsey Digital's new lead for the UK, Belgium, and Netherlands offices, spoke with Thomas Farrar, a manager of communications in the firm's UK office, about the importance of speed and pace for CEOs in this new growth journey. The British company works with organizations that pursue sustainability, inclusion, and economic growth, all at the same time, to achieve strategic foresight and built-in agility in the face of the COVID-19 pandemic and the new trading relationship with the EU. | Finance |